Life Sciences

Chinese CRO GemPharmatech Expands in San Diego as FDA R...

The Chinese contract research organization (CRO) GemPharmatech continues to incr...

Click Therapeutics Gains FDA Clearance for First Prescr...

Click Therapeutics has secured a notable regulatory milestone with the U.S. Food...

VelaVigo Bio Strikes Second Major Licensing Agreement, ...

In a continued series of strategic moves, VelaVigo Bio, a biotechnology firm bas...

Biolinq Secures $100 Million to Advance Glucose Biosens...

Biolinq has announced the successful closure of a $100 million venture capital i...

Roche offers $50 billion to US pharma production in res...

Roche, the drugmaker giant, announced its interest in investing $50 billion over...

J&J MedTech presents the first Ottava surgical robot cl...

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ott...

The late-stage research of Bristol Myers’ heart disease...

Bristol Myers Squibb disclosed that its drug stavartanate did not successfully i...

Merck Signs $493M Agreement to Use Cyprumed’s Oral Pept...

Merck & Co. is taking a significant step toward transforming its peptide therapi...

Sanofi Deepens Autoimmune Push with $1.8B AI Biotech Deal

Sanofi’s ambition to become a dominant force in immunology continues to take sha...

Lilly’s Orforglipron Demonstrates Semaglutide-Like Effi...

Eli Lilly’s oral GLP-1 receptor agonist orforglipron has met its primary efficac...

GSK’s Blenrep Returns with U.K. Approval for Multiple M...

GSK has received regulatory approval in the United Kingdom for two new combinati...

Vanda Challenges FDA Over Limits on Off-Label Drug Comm...

Vanda Pharmaceuticals is pushing back against the U.S. Food and Drug Administrat...

Pfizer Decides Against Pursuing Lead Obesity Asset Amid...

Pfizer said that it had discovered a possible instance of medication-induced liv...

Rallybio Drops Maternal Disorder Drug Following Phase 2...

US-based biotechnology company Rallybio is discontinuing its RLYB212 program for...

Trump’s Proposed Pharmaceutical Tariffs May Potentially...

The U.S. may soon impose significant tariffs on pharmaceutical imports, accordin...

Eli Lilly provides a $1.4 billion gene therapy contract...

Through its licensing deal with Eli Lilly, Sangamo Therapeutics received $18 mil...